Science Explorer Back to mapMap
Discussion
Company · Seongnam-si · South Korea

ABL Bio (South Korea)

ablbio.comROR OpenAlex
Research works
36
▲ 65% vs 2018-21
Citations
281
7.8 per fractional work
Top-10% rate
20.2%
all institutions 10.0%
Open access
53%
world 40%
International
24%
world 18%
ABL Bio (South Korea)

Not ranked overall: ABL Bio (South Korea) is under the volume floor below which a citation excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does ABL Bio (South Korea) work in?

In 2022-now, 70% of research at ABL Bio (South Korea) is in Health Sciences, 27% in Life Sciences. Its largest fields are Medicine (70%), Biochemistry, Genetics and Molecular Biology (16%), Immunology and Microbiology (7%). It does 2.3× the world's share of Health Sciences.

Health Sciences: 16 fractional works · 69.9% of its workMedicine: 16 fractional works · 69.9% of its workOncology: 7 fractional works · 32.1% of its workRadiology, Nuclear Medicine and Imaging: 6 fractional works · 23.7% of its workPulmonary and Respiratory Medicine: 1 fractional works · 4.5% of its workGenetics: 0 fractional works · 1.8% of its workNeurology: 0 fractional works · 1.7% of its workDermatology: 0 fractional works · 1.4% of its workEpidemiology: 0 fractional works · 1.2% of its workSurgery: 0 fractional works · 0.9% of its workEndocrinology, Diabetes and Metabolism: 0 fractional works · 0.7% of its workHematology: 0 fractional works · 0.7% of its workUrology: 0 fractional works · 0.7% of its workGastroenterology: 0 fractional works · 0.2% of its workLife Sciences: 6 fractional works · 27.3% of its workBiochemistry, Genetics and Molecular Biology: 4 fractional works · 16.2% of its workMolecular Biology: 3 fractional works · 13.0% of its workCancer Research: 0 fractional works · 1.4% of its workGenetics: 0 fractional works · 0.7% of its workBiotechnology: 0 fractional works · 0.6% of its workCell Biology: 0 fractional works · 0.5% of its workImmunology and Microbiology: 2 fractional works · 7.4% of its workImmunology: 2 fractional works · 7.4% of its workNeuroscience: 1 fractional works · 3.6% of its workCellular and Molecular Neuroscience: 0 fractional works · 2.1% of its workNeurology: 0 fractional works · 0.9% of its workDevelopmental Neuroscience: 0 fractional works · 0.5% of its workAgricultural and Biological Sciences: 0 fractional works · 0.2% of its workFood Science: 0 fractional works · 0.2% of its workPhysical Sciences: 1 fractional works · 2.8% of its workMaterials Science: 0 fractional works · 1.1% of its workBiomaterials: 0 fractional works · 1.1% of its workEngineering: 0 fractional works · 0.6% of its workBiomedical Engineering: 0 fractional works · 0.6% of its workChemistry: 0 fractional works · 0.5% of its workPhysical and Theoretical Chemistry: 0 fractional works · 0.5% of its workComputer Science: 0 fractional works · 0.3% of its workComputational Theory and Mathematics: 0 fractional works · 0.3% of its workMathematics: 0 fractional works · 0.3% of its workModeling and Simulation: 0 fractional works · 0.3% of its workALL ITS WORKABL Bio (SouthKorea)23fractional works, 2022-now
Life Sciences27%Physical Sciences3%Health Sciences70%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in 2022-now. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 3 domains and 10 fields, with their numbers
    1. Medicine1669.9%
    1. Biochemistry, Genetics and Molecular Biology416.2%
    2. Immunology and Microbiology27.4%
    3. Neuroscience13.6%
    4. Agricultural and Biological Sciences00.2%
    1. Materials Science01.1%
    2. Engineering00.6%
    3. Chemistry00.5%
    4. Computer Science00.3%
    5. Mathematics00.3%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.04× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 3.04× its world share, 4 worksBiochemistry, Geneti…Immunology and Microbiology: 7.33× its world share, 2 worksImmunology and Micro…Neuroscience: 2.19× its world share, 1 worksNeuroscienceChemistry: 0.30× its world share, 0 worksChemistryComputer Science: 0.04× its world share, 0 worksComputer ScienceEngineering: 0.04× its world share, 0 worksEngineeringMaterials Science: 0.31× its world share, 0 worksMaterials ScienceMathematics: 0.24× its world share, 0 worksMathematicsMedicine: 3.63× its world share, 16 worksMedicine1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 7.3×. Every wedge is a field page.

All 10 fields, with their numbers
  1. Immunology and Microbiology7.33×2 works
  2. Medicine3.63×16 works
  3. Biochemistry, Genetics and Molecular Biology3.04×4 works
  4. Neuroscience2.19×1 works
  5. Materials Science0.31×0 works
  6. Chemistry0.30×0 works
  7. Mathematics0.24×0 works
  8. Agricultural and Biological Sciences0.04×0 works
  9. Computer Science0.04×0 works
  10. Engineering0.04×0 works

Who are the top researchers at ABL Bio (South Korea)?

Ranked on the quality score, Jaeho Jung, Weon‐Kyoo You and Byungje Sung lead among researchers whose main affiliation is ABL Bio (South Korea).

  1. 1 Jaeho Jung South Korea · #820,134 worldwide 793 citations · 40 works
  2. 2 Weon‐Kyoo You South Korea · #1,212,000 worldwide 2.5k citations · 72 works
  3. 3 Byungje Sung South Korea · #1,219,627 worldwide 1.1k citations · 16 works
  4. 4 Yangsoon Lee South Korea · #1,615,400 worldwide 204 citations · 22 works
  5. 5 Kyeongsu Park South Korea · #2,162,212 worldwide 164 citations · 20 works
  6. 6 Jin-Hyung Ahn South Korea · #2,661,877 worldwide 234 citations · 26 works
  7. 7 Jonghwa Won South Korea · #2,915,607 worldwide 1.3k citations · 94 works
  8. 8 Yangmi Lim South Korea · #3,047,661 worldwide 32 citations · 48 works
All ranked researchers at ABL Bio (South Korea)

What are the most cited papers from ABL Bio (South Korea)?

The most cited paper from ABL Bio (South Korea) is "Targeting the DLL/Notch Signaling Pathway in Cancer: Challenges and Advances in Clinical Development" (Weon‐Kyoo You, Thomas J. Schuetz, Sang Hoon Lee, 2022), with 80 citations. Next come "LAG-3xPD-L1 bispecific antibody potentiates antitumor responses of T cells through dendritic cell activation" (80) and "Novel anti-4-1BB×PD-L1 bispecific antibody augments anti-tumor immunity through tumor-directed T-cell activation and checkpoint blockade" (58).

Most cited papers
#PaperReleasedCitations
1 Targeting the DLL/Notch Signaling Pathway in Cancer: Challenges and Advances in Clinical Development Weon‐Kyoo You, Thomas J. Schuetz, Sang Hoon Lee · Molecular Cancer Therapeutics Open access 12 Oct 2022 80
2 LAG-3xPD-L1 bispecific antibody potentiates antitumor responses of T cells through dendritic cell activation Eun-Sil Sung et al. · Molecular Therapy Open access 6 May 2022 80
3 Novel anti-4-1BB×PD-L1 bispecific antibody augments anti-tumor immunity through tumor-directed T-cell activation and checkpoint blockade Seongju Jeong et al. · Journal for ImmunoTherapy of Cancer Open access Jul 2021 58
4 B7-H3×4-1BB bispecific antibody augments antitumor immunity by enhancing terminally differentiated CD8 + tumor-infiltrating lymphocytes Gihoon You et al. · Science Advances Open access 15 Jan 2021 57
5 CLDN18.2 and 4-1BB bispecific antibody givastomig exerts antitumor activity through CLDN18.2-expressing tumor-directed T-cell activation Jing Gao, Zhengyi Wang, Wenqing Jiang et al. · Journal for ImmunoTherapy of Cancer Open access Jun 2023 49
All 42 most cited papers, with filters and sorting

Which keywords describe research at ABL Bio (South Korea)?

By fractional works in 2022-now, weighted toward what it does more of than the world: Glycosylation, Monoclonal Antibodies, Therapeutic Antibodies, Antibody Engineering, Fc Receptors, Chemotherapy, Monoclonal Antibody and Breast Cancer.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in 2022-now in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 29 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 29 words, with their numbers
  1. Glycosylation6▲ 251×3 topics
  2. Monoclonal Antibodies5▲ 247×2 topics
  3. Therapeutic Antibodies5▲ 318×2 topics
  4. Antibody Engineering5▲ 391×1 topic
  5. Fc Receptors5▲ 391×1 topic
  6. Chemotherapy3▲ 19×3 topics
  7. Breast Cancer3▲ 46×2 topics
  8. Immunotherapy3▲ 16×3 topics
  9. Monoclonal Antibody3▲ 215×2 topics
  10. Cancer Immunotherapy3▲ 74×2 topics
  11. Cancer2▲ 7.8×5 topics
  12. HER22▲ 319×1 topic
  13. Trastuzumab2▲ 204×1 topic
  14. Tumor Regression2▲ 88×2 topics
  15. CAR T Cells2▲ 132×1 topic
  16. Chimeric Antigen Receptor2▲ 132×1 topic
  17. Targeted Therapy2▲ 38×4 topics
  18. Tumor Microenvironment2▲ 19×2 topics
  19. Angiogenesis2▲ 22×3 topics
  20. Immune Checkpoint Blockade1▲ 51×1 topic
  21. PD-1 and PD-L11▲ 51×1 topic
  22. Inflammation1▲ 2.5×3 topics
  23. PET Imaging1▲ 31×2 topics
  24. Autoimmunity1▲ 33×2 topics
  25. Clinical Trials1▲ 7.3×3 topics
  26. Glycans1▲ 142×1 topic
  27. Immune System1▲ 19×1 topic
  28. Galectins1▲ 279×1 topic
  29. Immune Regulation1▲ 38×1 topic

Which research topics does ABL Bio (South Korea) publish most on?

By volume in 2022-now: Monoclonal and Polyclonal Antibodies Research, HER2/EGFR in Cancer Research, CAR-T cell therapy research and Cancer Immunotherapy and Biomarkers.

Monoclonal and Polyclona…5Monoclonal and Polyclonal Antibodies Research: 5 fractional worksHER2/EGFR in Cancer Rese…2HER2/EGFR in Cancer Research: 2 fractional worksCAR-T cell therapy resea…2CAR-T cell therapy research: 2 fractional worksCancer Immunotherapy and Biomarkers: 1 fractional worksGlycosylation and Glycoproteins Research: 1 fractional worksGalectins and Cancer Bio…1Galectins and Cancer Biology: 1 fractional worksPeptidase Inhibition and Analysis: 1 fractional worksLung Cancer Treatments and Mutations: 1 fractional worksRadiopharmaceutical Chemistry and Applications: 0 fractional worksColorectal Cancer Treatments and Studies: 0 fractional works
Radiology, Nuclear Medicine and ImagingOncologyMolecular BiologyImmunology1 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 5 works
  2. 2 HER2/EGFR in Cancer Research Oncology 2 works
  3. 3 CAR-T cell therapy research Oncology 2 works
  4. 4 Cancer Immunotherapy and Biomarkers Oncology 1 works
  5. 5 Glycosylation and Glycoproteins Research Molecular Biology 1 works
  6. 6 Galectins and Cancer Biology Immunology 1 works
  7. 7 Peptidase Inhibition and Analysis Oncology 1 works
  8. 8 Lung Cancer Treatments and Mutations Pulmonary and Respiratory Medicine 1 works
  9. 9 Radiopharmaceutical Chemistry and Applications Radiology, Nuclear Medicine and Imaging 0 works
  10. 10 Colorectal Cancer Treatments and Studies Oncology 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available53.0%not open47.0%

World: 40% of research is openly available.

with international co-authors24.4%domestic only75.6%

World: 18% is written across borders.

How has ABL Bio (South Korea)'s research output changed?

Output in 2022-2025 was 65% higher than in 2018-2021.

still counting20202025
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is ABL Bio (South Korea) as a percentage of every work published that year, 0.000043% in 2024.

still counting0.000050%0.00010%0.00015%ABL Bio (South Korea)0.000091% in 20252020

Fractional works of ABL Bio (South Korea) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Seongnam-si

All research institutions in Seongnam-si

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about ABL Bio (South Korea). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.